BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9436731)

  • 1. Epidemiological study of Guillain-Barré syndrome in south east England.
    Rees JH; Thompson RD; Smeeton NC; Hughes RA
    J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):74-7. PubMed ID: 9436731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré syndrome variants in Emilia-Romagna, Italy, 1992-3: incidence, clinical features, and prognosis. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology.
    Clinical E; Neurology EP
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):218-24. PubMed ID: 9703176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence, clinical manifestations, and prognosis of Guillain-Barré syndrome.
    Rantala H; Uhari M; Niemelä M
    Arch Dis Child; 1991 Jun; 66(6):706-8; discussion 708-9. PubMed ID: 2053793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients.
    Lyu RK; Tang LM; Cheng SY; Hsu WC; Chen ST
    J Neurol Neurosurg Psychiatry; 1997 Oct; 63(4):494-500. PubMed ID: 9343130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-specific incidence of Guillain-Barré syndrome in Oxfordshire.
    Winner SJ; Evans JG
    Q J Med; 1990 Dec; 77(284):1297-304. PubMed ID: 2290923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous gangliosides and Guillain-Barré syndrome. An observational study in the local health district of Ferrara, Italy.
    Govoni V; Granieri E; Tola MR; Paolino E; Casetta I; Fainardi E; Monetti VC
    Brain; 1997 Jul; 120 ( Pt 7)():1123-30. PubMed ID: 9236625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guillain-Barre syndrome. Current treatment principles in the light of clinical aspects].
    Gerdts R; Jensen D; Fauchald P; Skjeldal O
    Tidsskr Nor Laegeforen; 1999 Feb; 119(4):506-9. PubMed ID: 10081373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study on the incidence and prognosis of Guillain-Barré syndrome in Emilia-Romagna region, Italy (1992-1993). Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology.
    Neurology; 1997 Jan; 48(1):214-21. PubMed ID: 9008520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barre syndrome and Campylobacter jejuni infection. A study on the etiological characteristics of Guillain-Barre syndrome in China.
    Yuan JM; Tang J; Chen QT; Xiao L; Hao HJ; Jia ZD; Huang QH; Liu XZ
    Chin Med J (Engl); 1993 Nov; 106(11):845-7. PubMed ID: 8143497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological features of Guillain-Barré syndrome in Sweden, 1978-93.
    Jiang GX; Cheng Q; Link H; de Pedro-Cuesta J
    J Neurol Neurosurg Psychiatry; 1997 May; 62(5):447-53. PubMed ID: 9153599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood Guillain-Barré syndrome in Paraguay, 1990 to 1991.
    Hart DE; Rojas LA; Rosário JA; Recalde H; Román GC
    Ann Neurol; 1994 Dec; 36(6):859-63. PubMed ID: 7998771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh.
    Islam Z; Jacobs BC; van Belkum A; Mohammad QD; Islam MB; Herbrink P; Diorditsa S; Luby SP; Talukder KA; Endtz HP
    Neurology; 2010 Feb; 74(7):581-7. PubMed ID: 20157160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome.
    Ann Neurol; 1987 Dec; 22(6):753-61. PubMed ID: 2893583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome in south-west Stockholm, 1973-1991, 1. Quality of registered hospital diagnoses and incidence.
    Jiang GX; de Pedro-Cuesta J; Fredrikson S
    Acta Neurol Scand; 1995 Feb; 91(2):109-17. PubMed ID: 7785420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration to occurrence.
    Rantala H; Cherry JD; Shields WD; Uhari M
    J Pediatr; 1994 Feb; 124(2):220-3. PubMed ID: 8301426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré syndrome in Western Australia, 1980-1985.
    Hankey GJ
    Med J Aust; 1987 Feb; 146(3):130-3. PubMed ID: 3574191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Campylobacter jejuni infection and Guillain-Barré syndrome.
    Rees JH; Soudain SE; Gregson NA; Hughes RA
    N Engl J Med; 1995 Nov; 333(21):1374-9. PubMed ID: 7477117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré syndrome in Cantabria, Spain. An epidemiological and clinical study.
    Sedano MJ; Calleja J; Canga E; Berciano J
    Acta Neurol Scand; 1994 Apr; 89(4):287-92. PubMed ID: 8042448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré Syndrome: incidence, management and outcome of major complications.
    Moore P; James O
    Crit Care Med; 1981 Jul; 9(7):549-55. PubMed ID: 7238063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.